Shengxue Wang, Director of Strategic Development Department

Shengxue obtained her bachelor’s degrees of Economics and Applied Mathematics from the University of Minnesota，Twin Cities and master’s degree of Statistics from Columbia University, and qualified as the Chartered Financial Analyst (CFA) and a professional lawyer in China. She once worked in Perella Weinberg for M&A transactions, AIG Group for strategic advisory and operating performance analysis, and then in many public-listed medical companies such as Kanghong Pharmaceutical and Yuwell Medical for strategic planning, investment and financing, and global BD business development. She has been responsible for many large-scale international M&A, licensing and financing transactions, as well as post-investment management and the operation management of branches and subsidiaries. She focuses on the medical technology strategy, industry development and capital activities and has been selected as one of the 2021 China Zhongguancun U30 Young Entrepreneurs